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ABSTRACT
Phosphoprotein-binding domains (PPBDs) mediate
many important cellular and molecular processes.
Ten PPBDs have been known to exist in the human
proteome, namely, 14-3-3, BRCT, C2, FHA, MH2,
PBD, PTB, SH2, WD-40 and WW. PepCyber:P»PEP
is a newly constructed database specialized in
documenting human PPBD-containing proteins
and PPBD-mediated interactions. Our motivation is
to provide the research community with a rich
information source emphasizing the reported,
experimentally validated data for specific PPBD–
PPEP interactions. This information is not only
useful for designing, comparing and validating
the relevant experiments, but it also serves as a
knowledge-base for computationally constructing
systems signaling pathways and networks.
PepCyber:P»PEP is accessible through the URL,
http://www.pepcyber.org/PPEP/. The current
release of the database contains 7044 PPBD-
mediated interactions involving 337 PPBD-contain-
ing proteins and 1123 substrate proteins.
INTRODUCTION
Protein phosphorylation-mediated signal transduction is
an important post-translational modiﬁcation (PTM)-
based regulatory mechanism, and is implicated in a
broad spectrum of key cellular molecular processes,
including cell cycle, oncogenic transformation,
immunological responsiveness, apoptosis and develop-
ment (1–5). In these activities, ‘phosphoprotein-binding
domains’ (PPBDs, denoting domains that have speciﬁc
binding aﬃnity to phosphorylated sites in proteins) play a
pivotal role in connecting the kinases and the eﬀector
molecules, forming multi-protein complexes, and inducing
speciﬁc protein–protein interactions responsible for
changes in these proteins’ subcellular localization, folding
state, binding speciﬁcity or activity (6). PPBDs achieve
their binding speciﬁcity to their substrate proteins
primarily through the recognition of a phosphopeptide
(PPEP) region, which are short peptide sequences (6–15
residues) containing phosphorylated residues (i.e. pS,
pT or pY, where S is serine, T is threonine and Y is
tyrosine) (1,7). Other factors, such as the tertiary
structures, subcellular localization of the substrate pro-
teins, as well as domain competition, are also known
to inﬂuence PPBD–phosphoprotein interactions in vivo
(7,8). Phosphorylation sites are frequently found in
intrinsically disordered or unstructured regions of the
proteins (9–11), making these regions good candidate sites
for PPBD binding. In the human proteome, 10 protein
domains—14-3-3, BRCT, C2, FHA, MH2, PBD, PTB,
SH2, WD-40 and WW—have been identiﬁed as PPBDs,
i.e. they possess phosphoprotein or PPEP-binding activ-
ities (Table 1).
The interactions between PPBDs and their PPEP
substrates have been studied extensively using a variety
of techniques, including structural determination (using
X-ray crystallography or NMR spectroscopy), peptide
assay (using phage display, synthetic peptide library or
oriented peptide library), combinatorial screening, mass
spectrometry analysis, mutagenesis (usually followed
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putational sequence analysis (3). The rich information
generated by these means is now partially captured by a
few database resources, where the information about
PPBDs, PPBD-containing proteins and their interactions
with PPEP-containing substrate proteins can be obtained.
These resources include general protein–protein inter-
action databases such as BIND (12), HPRD (13) and
DOMINO (14), functional motif databases such as ELM
(8) and Phospho.ELM (15), and a specialized prediction
server—Scansite, which makes predictions about the
PPBD–PPEP interactions based on results obtained
from oriented peptide library experiments (16). Despite
the availability of these existing resources, a database that
oﬀers integrated, comprehensive, detailed annotations
regarding the proteomic interactions mediated by
PPBDs is still lacking.
PepCyber:PPEP was constructed with the intention of
ﬁlling this gap. In PepCyber:PPEP, the information
about PPBD-mediated protein interactions was carefully
compiled through curation of peer-reviewed publications,
and deposited into a relational database. For each
interaction, speciﬁc information about the PPBD,
PPBD-containing protein, the speciﬁc PPEP substrate
bound, the substrate protein, the evidence of the interac-
tion and the citations were recorded. Moreover, informa-
tion regarding the signaling pathways associated with
the PPBD–PPEP-binding interactions (in particular,
tumorigenesis-related signaling pathways and tumor
types) is also documented and stored in the database.
The data hosted in PepCyber:PPEP meet the Human
Proteome Organization (HUPO), Proteomics Standards
Initiative (PSI) standard (17), which is supported by most
major protein–protein interaction databases.
UTILITY
Data content
We term an occurrence of a PPBD in a speciﬁc protein a
‘PPBD instance’, and the collection of similar PPBD
instances with a high level of sequence homology and
structural similarity a ‘PPBD class’. For example, the SH2
domain located close to the N-terminus of the protein,
PTPN11 (SHP2), is an ‘instance’ belonging to the SH2
‘PPBD class’. Presently, there are 10 reported human
PPBD classes (Table 1). The current PepCyber:PPEP
release (V.1.0, release 31 July 2007) includes 7044
PPBD-mediated interactions involving 337 PPBD-
containing proteins and 1123 substrate proteins. This
rich information was obtained through the curation of
2446 peer-reviewed research articles published between
1975 and 2007. The largest number of interactions
involves the SH2 PPBD class (4290 interactions) that
is followed by the WW PPBD class (1389 interactions)
and 14-3-3 PPBD class (1086 interactions). These inter-
actions were classiﬁed into three categories based on
whether the interaction was known to be mediated by a
concerned PPBD instance, and whether the substrate
peptide had been identiﬁed: if the interaction was known
to be mediated by a PPBD instance and the substrate
peptide had been identiﬁed, the interaction was classiﬁed
as ‘category A’; if the interaction was known to be
mediated by a PPBD instance but the substrate peptide
had not been identiﬁed, the interaction is classiﬁed as
‘category B’; if it was not known whether the interaction
was mediated by a PPBD instance (though one of the
interacting proteins was a PPBD protein), then the
interaction was classiﬁed as ‘category C’. Among
the 7044 interactions documented in the current release
of PepCyber:PPEP, 5376 (76%) are category A
interactions.
The 14-3-3, PTB and WW PPBD classes are unique in
that they are also capable of binding to non-PPEP
substrates in certain instances. These non-PPEP interac-
tions are also documented in PepCyber:PPEP. There
are a total of 1068 non-PPEP interactions, accounting
for 15% of the total collection of the current
PepCyber:PPep release. All non-PPEP interactions
documented are category A interactions.
Web interface
The web interface of the PepCyber:PPEP database can
be accessed through the URL http://www.pepcyber.org/
PPEP/. Five tabs are located underneath the logo of
Table 1. Summary of the 10 human PPBD classes
PPBD (class name) Reported substrate speciﬁcity
a Refs.
14-3-3 R-S-X-pS-X-P, R-X-X-X-pS-X-P (1,20)
BRCT pS-X-X-F (21,22)
C2 (Y/F)-(S/A)-(V/I)-pY-(Q/R)-X-(Y/F)-X (23)
FHA (Forkhead-associated) pT-X-X-D (24,25)
MH2 (MAD homology 2) pS-X-pS (26)
PBD (Polo-Box domain) S-(pT/pS)-(P/X) (27)
PTB (phosphotyrosine binding) N-P-X-pY, N-P-X-Y (28)
SH2 (Src homology 2) pY-X-X-(I/P) (CRK); pY-(I/V/L)-X-(I/V/L)
(PTPN11); pY-(M/I/L/V/E)-X-M (PIK3R1)
(29,30)
b
WD-40 D-pS-G--X-pS (BTRC); (I/L/P)-(I/L/P)-pT-P (FBXW7) (31,32)
WW (A/P)-P-P-(A/P)-Y; pS-P; pT-P (33)
aThe listed information is representative of the vast amount of literature information.
bThe information also includes our unpublished data on SH2-PPEP microarray data.
D680 Nucleic Acids Research, 2008, Vol. 36, Databaseissuethe web site, namely, ‘PPBD Classes’, ‘PPBD Proteins’,
‘Interaction Search’, ‘Tutorial’ and ‘Glossary’. These ﬁve
tabs are described subsequently.
The ‘PPBD Classes’ tab leads to the introduction pages
of the 10 PPBD classes (Table 1), where information
about the lengths, structures, representative instances and
the reported binding speciﬁcity for each of the 10 PPBD
classes is presented.
The ‘PPBD Proteins’ tab leads to the PPBD-containing
proteins browsing page, where the user can select a PPBD-
containing protein to view the details for the protein of
interest, including the gene symbol, description, NCBI
RefSeq and Swiss-Prot accessions and a graphical
representation of all PPBD-mediated interactions invol-
ving this protein. The information regarding the inter-
actions involving each PPBD instance of the protein is
then listed separately. When the number of the known
interactions involving a domain is suﬃciently large (510),
the positional amino acid composition preference of the
substrate sequences (17 amino acid long) is also available
as a WebLogo image (18).
The ‘Interaction Search’ tab leads to the page where
custom search functions can be executed. The user has
multiple search options for the PPBD–PPEP interactions:
by the PPBD class; by the PPBD instance; by the name,
NCBI RefSeq accession or Swiss-Prot accession of either
the PPBD protein or the substrate protein; by the
substrate peptide sequence, or by the pathway involved.
The search can also be conducted using any combinations
of the above criteria. The search result is presented as
a list of interactions, each with the names of the PPBD-
containing protein and the substrate protein, the substrate
sequence, index site, evidence type, category of the
interaction and the number of records matching the
interaction. The ‘index site’ refers to the locus of
the phosphorylated residue on a PPEP substrate protein,
or the locus of the central contact residue on a non-PPEP
substrate protein. The ‘evidence type’ indicates the type
of analysis conducted to support the presence of the
interaction. Currently, four evidence types are deﬁned:
(i) structural determinations; (ii) peptide library experi-
ments; (iii) mutagenesis and (iv) sequence analyses.
By clicking the ‘Details’ link for each listed interaction,
the user can view more detailed information about
the interaction, including the names, NCBI RefSeq
accessions, Swiss-Prot accessions of the PPBD-containing
protein and the substrate protein, the sequence of
the substrate protein, the evidence type and the references
for the interactions reported. The user can choose to
plot all interactions or a selected set of interactions as
PPBD-mediated protein–protein interaction networks.
The network graphs are rendered dynamically using the
graph visualization software, GraphViz (19). In the
network plot, each node represents one protein: PPBD-
containing proteins are labeled in green, and other
proteins are labeled in yellow. Each directed edge
represents an interaction between a PPBD instance and
substrate protein, with the index site displayed on
the edge. The user can click on a node representing a
PPBD-containing protein to reach the PPBD protein
information page.
The ‘Tutorial’ tab leads to the page where the utility
of the database is demonstrated in a graphical
manner. The ‘Glossary’ tab leads to the glossary page
where terms and abbreviations used in the web site are
explained.
Data access
PepCyber:PPEP is publicly accessible through the URL
http://www.pepcyber.org/PPEP/and the data sets are
available, free of charge, to researchers from academic
and non-proﬁt institutions. Additional requests can be
made by emailing to help@pepcyber.org.
Implementation
The PepCyber:PPEP database is a relational database
implemented with MySQL on a Fedora Core 2 Linux
system. The front-end web interface is implemented as
a PHP project running under Apache 2.0.
COMPARISON WITH DATABASES RELEVANT
TO PPBPS AND/OR PPEPS
PepCyber:PPEP is the ﬁrst database specialized in
documenting human PPBDs, PPBD-containing proteins
and PPBD-mediated protein–protein interactions.
However, the information about human PPBDs and
PPBD-mediated interactions is also hosted in existing
general protein–protein interaction databases such as
BIND (12), HPRD (13) and DOMINO (14), and
functional motif databases such as ELM (8) and
Phospho.ELM (15). All these databases have diﬀerent
focuses, and as such the types of information stored vary
among them (Table 2).
PepCyber:PPEP hosts a substantially richer collection
of data about PPBD-mediated interactions than any other
database. Table 3 provides a quantitative comparison
between PepCyber:PPEP and the existing databases in
the number of PPBD instances and PPBD-mediated
interactions. In addition to this advantageous depth and
breadth of information, the PepCyber:PPEP data
collection is also of notably high quality, attributed to
the meticulous data curation procedure followed and the
rigorous quality control (QC) process carried out before
the data is deposited into the MySQL database. For
example, special attention was given to allow synonymous
protein symbols used in the search, allowing a user to
obtain consistent results, as diﬀerent original studies may
use diﬀerent symbols to represent the same gene or
protein. During data curation, each gene/protein
symbol used in the original articles was checked against
three databases—NCBI GenBank, Swiss-Prot and NCBI
Entrez Gene to ensure that diﬀerent symbols (or
synonyms) of the same gene/protein are represented by
the same entity in the data set. During QC, the curated
entries were checked against a local copy of the three
public gene/protein databases. If any inconsistency was
identiﬁed, the entry was returned to the curation process
for re-checking. These procedures guarantee that only
high-conﬁdence data were deposited into the released
PepCyber:PPEP database. Problems with gene/protein
Nucleic Acids Research, 2008,Vol. 36,Database issue D681symbols that occur from time to time in other data-
bases were minimized. As an example of such
problems, three symbols—SHP2, SHP-2 and SHPTP2—
were used in diﬀerent entries in Phospho.ELM, without
indication that they are all synonyms of the same gene
PTPN11.
FUTURE DIRECTIONS
Pepcyber:PPEP is intended to provide comprehensive,
up-to-date, dynamic information and tools to researchers
who require information on PPBD-mediated protein–
protein interactions as well as the sequence patterns and
connecting maps of these interactions in the human
proteome. The reported information herein represents an
initial step toward our long-term goals. Our continuing
eﬀort will be in the following several areas: (i) Update and
expand the content and functions of PepCyber:PPEP
as published studies on the PPBDs and PPBD-mediated
interactions continue to accumulate; (ii) develop and
implement novel analysis methods of proteins and
peptides to mine the rich data compilation stored in
PepCyber:PPEP; (iii) develop strategies and methods to
predict substrate speciﬁcity for one or more PPBD
instances within a PPBD class and (iv) develop necessary
tools for systems biology modeling using the
PepCyber:PPEP data. These developments will comple-
ment experimental eﬀorts, lead to savings in time and cost
in experiments, and accelerate our understanding of the
key processes in cellular regulation mechanisms. We
envision that such an information source will have
signiﬁcant value for not only proteomic research, but
also for discovery and development of drug candidates,
drug targets and biomarkers.
PepCyber:PPEP is merely the ﬁrst signiﬁcant compo-
nent of the overall PepCyber, a valuable information
source for important peptide-related biological and
biomedical subject areas. The PepCyber eﬀort will
eventually result in a suite of database resources and
computational tools assisting the development of peptide
microarray-based proteomics proﬁling analysis. Future
developments of PepCyber will include database resources
with expanded scopes, e.g. non-PPBD-mediated protein–
protein interactions, as well as non-database components
such as peptide microarray design and data analysis tools.
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Table 3. A quantitative comparison between PepCyber:PPEP and similar databases in the numbers of PPBD instances, PPBD-mediated
interactions for all PPBD classes as well as for the four most popular PPBD classes: 14-3-3, PTB, SH2 and WW
Database #PPBD
instances
#PPBD-mediated
interactions
#14-3-3-mediated
interactions
#PTB-mediated
interactions
#SH2-mediated
interactions
#WW-mediated
interactions
BIND 81 149 4 19 82 4
HPRD 57 105 7 7 82 1
DOMINO 195 1020 234 85 468 157
ELM 14 68 20 0 47 1
Phospho.ELM 47 220 0 11 209 0
PepCyber:P»PEP 337 7044 1086 158 4290 1389
Bold indicates that PepCyber:PPEP is the database we are presenting, and that it is superior to other databases in comparison.
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